🔗 Share this article

Chancellor Rachel Reeves has stated she is preparing "specific measures to address cost of living issues" in the forthcoming financial statement.

In comments to the BBC, she noted that reducing inflation is a shared duty of both the government and the Bank of England.

The UK's inflation rate is projected to be the most elevated among the G7 developed nations this calendar year and next.

Potential Energy Cost Measures

Sources suggest the government could intervene to lower utility costs, for instance by slashing the present 5% rate of value-added tax applied on energy.

Another approach is to reduce some of the government charges presently included in bills.

Budgetary Limitations and Expert Expectations

The administration will receive the latest report from the independent fiscal watchdog, the OBR, on Monday, which will clarify how much room there is for such actions.

The expectation from most analysts is that Reeves will have to declare higher taxes or budget cuts in order to meet her declared debt limits.

Earlier on the same day, analysis showed there was a £22bn shortfall for the Treasury chief to resolve, which is at the more modest range of projections.

"There's a shared job between the central bank and the government to further reduce some of the sources of price increases," the Chancellor informed the BBC in Washington, at the conferences of the IMF and global financial institution.

Revenue Pledges and International Concerns

While much of the attention has been on expected tax rises, the chancellor said the most recent information from the fiscal watchdog had not changed her pledge to campaign commitments not to raise tax levels on earnings tax, VAT or social security contributions.

She blamed an "unpredictable global environment" with rising geopolitical and trade tensions for the fiscal revenue measures, likely to be targeted on those "wealthiest."

International Trade Tensions

Addressing concerns about the United Kingdom's commercial links with the Asian nation she said: "Our national security invariably take priority."

Last week's announcement by China to strengthen export controls on rare earths and other resources that are essential for high-technology manufacturing led US President the US President to threaten an further 100% import tax on goods from the Asian country, increasing the possibility of an full-scale trade war between the two global powers.

The American finance chief described the Chinese action "commercial pressure" and "a international production control attempt."

Asked about accepting the US offer to participate in its conflict with China, Reeves said she was "extremely troubled" by Chinese measures and urged the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "harmful for the international commerce and causes further challenges."

"It is my opinion there are fields where we need to address Chinese policies, but there are also valuable opportunities to export to Chinese markets, including banking sector and other sectors of the economy. We've got to get that equilibrium appropriate."

The Treasury chief also confirmed she was cooperating with international partners "on our own essential resources strategy, so that we are more independent."

Health Service Medicine Pricing and Funding

Reeves also admitted that the cost the NHS spends on pharmaceuticals could go up as a consequence of ongoing negotiations with the Trump administration and its drugs companies, in return for lower tariffs and capital.

A number of the world's largest drug companies have said in recent statements that they are either halting or canceling investments in the UK, with some attributing the insufficient payments they are getting.

Last month, the Science Minister said the cost the health service spends on medicines would have to go up to prevent businesses and pharmaceutical investment departing from the United Kingdom.

Reeves told the BBC: "It has been observed because of the cost structure, that clinical trials, innovative medicines have not been available in the United Kingdom in the way that they are in other EU nations."

"We want to ensure that patients receiving care from the NHS are can obtain the finest life-saving drugs in the globe. And so we are looking at these issues, and... seeking to obtain increased funding into the UK."